![Nicklas Westerholm](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicklas Westerholm
Chief Executive Officer at
EGETIS THERAPEUTICS AB
Net worth: 330 238 $ as of 2026-05-30
Profile
Nicklas Westerholm is currently Chief Executive Officer at Egetis Therapeutics AB since 2017, Chairman & Chief Executive Officer at Rare Thyroid Therapeutics International AB, and Independent Director at Spago Nanomedical AB since 2019.
Former positions include Head-Investor Relations at AstraZeneca PLC from 2011 to 2013 and VP-Project & Portfolio Management at AstraZeneca AB from 1995 to 2017.
Education includes undergraduate studies at the University of Stockholm and the Royal Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-12 | 501,508 ( 0.11% ) | 330 238 $ | 2026-05-30 |
Nicklas Westerholm active positions
| Companies | Position | Start |
|---|---|---|
| EGETIS THERAPEUTICS AB | Chief Executive Officer | 2017-06-15 |
| SPAGO NANOMEDICAL AB | Director/Board Member | 2019-05-07 |
Rare Thyroid Therapeutics International AB
 Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Provides thyroid therapeutics research services | Chief Executive Officer | - |
Former positions of Nicklas Westerholm
| Companies | Position | End |
|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | 2017-05-31 |
| ASTRAZENECA PLC | Investor Relations Contact | 2011-09-07 |
Training of Nicklas Westerholm
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
30
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
University of Stockholm
 University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Egetis Therapeutics AB
 Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Spago Nanomedical AB
 Spago Nanomedical AB BiotechnologyHealth Technology Acts as a biotechnology company | Health Technology |
Rare Thyroid Therapeutics International AB
Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Provides thyroid therapeutics research services | Health Technology |
- Stock Market
- Insiders
- Nicklas Westerholm
